Gastroenterology - Google Scholar Metrics

h5-index:148
h5-median:222

h5-index is the h-index for articles published in the last 5 complete years. It is the largest number h such that h articles published in 2016-2020 have at least h citations each.hide

h5-median for a publication is the median number of citations for the articles that make up its h5-index.hide

Title / Author	Cited by	Year
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease P Angulo, DE Kleiner, S Dam-Larsen, LA Adams, ES Bjornsson, ... Gastroenterology 149 (2), 389-397. e10	1166	2015
The Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Population-Based Studies SC Ng, HY Shi, N Hamidi, FE Underwood, W Tang, EI Benchimol, JC Wu, ... Gastroenterology 152 (5), S970-S971	1060	2017
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States RJ Wong, M Aguilar, R Cheung, RB Perumpail, SA Harrison, ... Gastroenterology 148 (3), 547-555	1013	2015
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV DA Drossman Gastroenterology 150 (6), 1262-1279. e2	876	2016
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma J Bruix, M Reig, M Sherman Gastroenterology 150 (4), 835-853	848	2016
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial P Moayyedi, MG Surette, PT Kim, J Libertucci, M Wolfe, C Onischi, ... Gastroenterology 149 (1), 102-109. e6	818	2015
Bowel Disorders BE Lacy, F Mearin, L Chang, WD Chey, AJ Lembo, M Simren, R Spiller Gastroenterology 150 (6), 1393-1407. e5	766	2016
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis E Vilar-Gomez, Y Martinez-Perez, L Calzadilla-Bertot, A Torres-Gonzalez, ... Gastroenterology 149 (2), 367-378. e5	741	2015
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ... Gastroenterology 149 (3), 649-659	722	2015
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis JKY Hooi, WY Lai, WK Ng, MMY Suen, FE Underwood, D Tanyingoh, ... Gastroenterology 153 (2), 420-429	614	2017
Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction DA Drossman, WL Hasler Gastroenterology 150 (6), 1257-1261	608	2016
Gastroduodenal Disorders V Stanghellini, FKL Chan, WL Hasler, JR Malagelada, H Suzuki, J Tack, ... Gastroenterology 150 (6), 1380-1392	602	2016
Childhood Functional Gastrointestinal Disorders: Child/Adolescent JS Hyams, C Di Lorenzo, M Saps, RJ Shulman, A Staiano, M van Tilburg Gastroenterology 150 (6), 1456-1468. e2	575	2016
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis NG Rossen, S Fuentes, MJ van der Spek, JG Tijssen, JHA Hartman, ... Gastroenterology 149 (1), 110-118. e4	572	2015
Colorectal Cancer Screening: Recommendations for Physicians and Patients From the US Multi-Society Task Force on Colorectal Cancer DK Rex, CR Boland, JA Dominitz, FM Giardiello, DA Johnson, ... Gastroenterology 153 (1), 307-323	550	2017
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease NV Casteele, M Ferrante, G Van Assche, V Ballet, G Compernolle, ... Gastroenterology 148 (7), 1320-1329. e3	550	2015
Bowel Disorders. F Mearin, BE Lacy, L Chang, WD Chey, AJ Lembo, M Simren, R Spiller Gastroenterology	521	2016
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States AF Peery, SD Crockett, AS Barritt, ES Dellon, S Eluri, LM Gangarosa, ... Gastroenterology 149 (7), 1731-1741. e3	515	2015
American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts SS Vege, B Ziring, R Jain, P Moayyedi, MA Adams, SD Dorn, ... Gastroenterology 148 (4), 819-822	507	2015
Elafibranor, an Agonist of the Peroxisome Proliferator− Activated Receptor− α and− δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ... Gastroenterology 150 (5), 1147-1159. e5	501	2016

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.